W588C
Category 4 — Stable Fold, Function DisruptedUncertain significanceTransmembrane · predictedSource cardInteractive 3D Structure
Bond changes · DynaMut2 interaction analysis
| Interaction type | Wild-type partner | Mutant partner | Status |
|---|---|---|---|
| Hydrogen bond | Q584 | Q584 | Preserved |
| Hydrogen bond | F585 | — | Lost |
| Hydrogen bond | S591 | S591 | Preserved |
| Hydrogen bond | L592 | L592 | Preserved |
| Polar contact | Q584 | Q584 | Preserved |
| Polar contact | F585 | F585 | Preserved |
| Polar contact | A586 | A586 | Preserved |
| Polar contact | T590 | — | Lost |
| Polar contact | S591 | S591 | Preserved |
| Polar contact | L592 | L592 | Preserved |
| Aromatic / π | F585 | — | Lost |
| Van der Waals | L592 | — | Lost |
| Van der Waals | T600 | — | Lost |
| Hydrophobic | F585 | — | Lost |
| Hydrophobic | L592 | — | Lost |
| Hydrophobic | T600 | — | Lost |
Lost / gained / preserved interatomic contacts at the variant residue, from the DynaMut2 (Arpeggio) interaction analysis of the wild-type and energy-minimized mutant structures.
Computational Predictions
Clinical Evidence
Observed at very low frequency in gnomAD.
Full Variant Card
WFS1 Wolframin — W588C Variant Card
Molecular Atlas Pilot · RareResearch.AI · Generated by wolfram-variant-card skill
Tryptophan → Cysteine at position 588. Transmembrane helix 9. ClinVar Uncertain significance, AlphaMissense 0.527, DynaMut2 ΔΔG -0.36 kcal/mol (destabilising).
Identity
| Field | Value |
|---|---|
| Variant | W588C (p.Tryptophan588Cysteine) |
| DNA change | c.1764G>T |
| Gene · Protein | WFS1 · Wolframin (890 aa) |
| UniProt | O76024 · WFS1_HUMAN |
| ClinVar accession | VCV001407986 |
| Amino acid change | Tryptophan (W) → Cysteine (C) |
Structural Context
| Field | Value |
|---|---|
| AlphaFold model | AF-O76024-F1, v6 |
| pLDDT at residue 588 | 72.88 — well-folded |
| Domain | Transmembrane helix 9 |
| Position context | Inside Transmembrane helix 9 · position 588 is bilayer-embedded |
| IDR flag | No — pLDDT above 50 threshold |
UniProt features at this position:
(none catalogued)
Position 588 sits in a transmembrane helix (Transmembrane helix 9). Wolframin has eleven such helices anchoring it in the ER membrane; substitutions inside the bilayer-embedded segments can disrupt helix packing, lipid contacts, and the overall ER topology of the protein. The wild-type residue is bulky aromatic (tryptophan — indole ring); the mutant is thiol (cysteine — disulfide-capable, free -SH). The chemistry shift implies altered local packing, hydrogen-bonding, and/or electrostatics at this site.
Computational Predictions
AlphaMissense
| Field | Value |
|---|---|
| am_pathogenicity | 0.5273 |
| am_class | ambiguous |
| Interpretation | Likely benign (threshold 0.564) |
DynaMut2
| Field | Value |
|---|---|
| ΔΔG (kcal/mol) | -0.36 (Destabilising) |
| Job ID | 178094730681 |
| Result URL | https://biosig.lab.uq.edu.au/dynamut2/results_prediction/178094730681 |
Clinical Evidence
| Field | Value |
|---|---|
| Classification | Uncertain significance |
| Review status | criteria provided, multiple submitters, no conflicts |
| Last evaluated | 2025/05/03 00:00 |
| Inheritance | Autosomal dominant pattern indicated by associated DFNA6/14/38 (WFS1 hearing loss 6). |
| WFS1 variant landscape | W588C is 1 of ~326 pathogenic-spectrum variants in WFS1 (out of 2,243 catalogued in ClinVar) |
- Cataract 41
- Autosomal dominant nonsyndromic hearing loss 6
- Type 2 diabetes mellitus
- Wolfram-like syndrome
- Wolfram syndrome 1
Research Path Decision Tree
ΔΔG < 2 + binding site affected → CATEGORY 3 — docking experiments
ΔΔG 2–4 → CATEGORY 2 — pharmacological chaperones
ΔΔG > 4 → CATEGORY 1 — gene therapy
pLDDT < 50 → CATEGORY 5 — IDR, experimental only
Stable fold + functional site hit → CATEGORY 4 — site-specific docking
Final Schema Categorization
Category 4 — Stable Fold, Function Disrupted
<strong>Category 4 — Stable Fold, Function Disrupted</strong><br/><br/>|ΔΔG|=0.36 negligible. Likely site-specific functional disruption — docking strategy.
Why this card matters. Wolframin's fold survives this substitution (|ΔΔG|=0.36 kcal/mol). The pathogenic signal is real — AlphaMissense places it at 0.527. Protein still folds, but a specific local site is broken. Pharmacological chaperones and small-molecule binders are the rational therapeutic vector.
Files in this folder
AF-O76024-F1-model_v6.pdb— AlphaFold structureW588C_molstar_viewer.html— interactive 3D viewer (auto-highlights position 588 with ball-and-stick + neighbors within 5Å)W588C_variant_card.md— this card (source of truth)W588C_variant_card.html— styled printable cardW588C_dynamut2_summary.html— clean offline DynaMut2 result carddynamut2_result.json— structured result datadynamut2_result_page.html— local snapshot of the Biosig result page (asset URLs absolutized)W588C_wildtype_interactions.pse/W588C_mutant_interactions.pse— PyMOL sessions
Generated by wolfram-variant-card skill · RareResearch.AI Molecular Atlas Every assumption documented. Every score sourced.
Feed this card to Wolfram Intelligence
Download the W588C PDF below and upload it to Wolfram Intelligence to generate therapeutic-strategy proposals — guanidinium mimetics, sigma-1 agonist docking, NAC thiol-capping. NAC is already on the bench-testing list.